Bleichmar Fonti & Auld LLP & ADMA Biologics

Bleichmar Fonti & Auld LLP: Bleichmar Fonti & Auld LLP is a law firm investigating ADMA Biologics for potential violations of federal securities laws and encouraging investors to join a class action lawsuit.

ADMA Biologics: ADMA Biologics is the primary subject of the class action lawsuits and investigations due to allegations of channel stuffing, undisclosed related-party transactions, and misleading revenue growth, which caused its stock price to decline significantly.

Bleichmar Fonti & Auld LLP: Bleichmar Fonti & Auld LLP is one of the law firms representing investors in the class action. The firm benefits from potential fees if the case is successful.

ADMA Biologics: ADMA Biologics is the defendant in the securities class action, accused of making false and misleading statements. The lawsuit and allegations have led to a significant drop in its stock price and could result in substantial financial penalties and reputational harm.